Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab-Reference-Cited by-同舟云学术

Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab

Published:2017-09-26 Issue:24 Volume:23 Page:7474-7482
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Yi John S.,Ready Neal,Healy Patrick,Dumbauld Chelsae,Osborne Robyn,Berry Mark,Shoemaker Debra,Clarke Jeffrey,Crawford Jeffrey,Tong Betty,Harpole David,D'Amico Thomas A.,McSherry Frances,Dunphy Frank,McCall Shannon J.,Christensen Jared D.,Wang Xiaofei,Weinhold Kent J.

Funder

BRPCDIPC

Duke University

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions;Cancers;2024-08-19

2. Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients;International Immunopharmacology;2024-08

3. Clinical implication of PRAME immunohistochemistry in differentiating melanoma in situ and dysplastic nevus in non‐acral nevus‐associated melanoma in situ: An institutional experience and meta‐analysis;Journal of Cutaneous Pathology;2024-06-21

4. Systemic Inflammation, the Peripheral Blood Transcriptome, and Primary Melanoma;Journal of Investigative Dermatology;2024-04

5. Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T‐cell costimulator as a crucial immune checkpoint molecule;Cancer Medicine;2024-03